Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions

NCT06871046 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Contusions

Interventions

DRUG: Esflurbiprofen Topical System (EFTS)

Sponsor

Teikoku Seiyaku Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]